HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

estradiol 17 beta-cypionate (Depo-estradiol)

structure
Also Known As:
Depo-estradiol; estradiol cypionate; estradiol 17 beta-cyclopentylpropionate; estradiol 17 beta-cyclopentanepropionate
Networked: 22 relevant articles (1 outcomes, 6 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Divelbiss, Raymond D: 1 article (01/2013)
2. Hollingshead, Melinda G: 1 article (01/2013)
3. Gonzalez, Frank J: 1 article (01/2013)
4. Bonzo, Jessica A: 1 article (01/2013)
5. Manna, Soumen K: 1 article (01/2013)
6. Krausz, Kristopher W: 1 article (01/2013)
7. Johnson, Caroline H: 1 article (01/2013)
8. Cárnio, E C: 1 article (12/2011)
9. Saia, R S: 1 article (12/2011)
10. Bertozi, G: 1 article (12/2011)

Related Diseases

1. Pyometra
2. Hemorrhage
01/01/1991 - " 2328 women from 12 countries participated in trials of DMPA 25 mg-estradiol cypionate 5 mg, and NET-EN 50 mg-estradiol valerate 5 mg. The continuation rate was better than that for 3-monthly progestogen-only injectables, because of less irregular bleeding. "
10/01/1987 - "A multicentered study was undertaken at three institutions in Hungary, Mexico and Thailand in women of reproductive age to evaluate the effects of full and half doses of HRP112 (depot-medroxyprogesterone acetate (DMPA) plus estradiol cypionate) and DMPA alone on ovarian function, bleeding patterns and HDL-cholesterol levels. "
01/01/2008 - "Combination injectable contraceptives include depot medroxyprogesterone acetate (DMPA) 25 mg plus estradiol cypionate (E(2)C) 5 mg, as well as norethisterone enanthate (NET-EN) 50 mg plus estradiol valerate (E(2)V) 5 mg. These contraceptives resulted in lower rates of early study discontinuation due to amenorrhea or other bleeding problems than progestin-only contraceptives. "
01/01/2005 - "Combination injectable contraceptives include depot medroxyprogesterone acetate (DMPA) 25 mg plus estradiol cypionate (E(2)C) 5 mg, as well as norethisterone enanthate (NET-EN) 50 mg plus estradiol valerate (E(2)V) 5 mg. These combination injectable contraceptives resulted in lower rates of early study discontinuation due to amenorrhea or other bleeding problems, but had higher rates of discontinuation due to other reasons than the progestin-only comparison contraceptives. "
12/01/2000 - "Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives."
3. Amenorrhea
4. Migraine Disorders (Migraine)
5. Body Weight (Weight, Body)

Related Drugs and Biologics

1. Estrogens (Estrogen)
2. N,N-dimethyl-4-anisidine (DMPA)
3. Medroxyprogesterone Acetate (Depo-Provera)
4. estradiol valerate (Delestrogen)
5. Contraceptive Agents (Contraceptives)
6. CycloProvera
7. norethindrone enanthate
8. HDL Cholesterol
9. Progesterone
10. Lunelle

Related Therapies and Procedures

1. Injections
2. Contraception (Birth Control)
3. Intravenous Injections
4. Aftercare (After-Treatment)